QuikClot® EMS hemostatic devices are a life-saving technology that every first responder needs

Trauma is a major cause of death and disability and the second most expensive healthcare problem in the United States. Approximately 40% of trauma-related deaths are due to bleeding or its consequences, establishing hemorrhage as the most common cause of preventable death in trauma.9

With QuikClot® hemostatic devices, first responders save critical time by stopping bleeding within minutes of application. QuikClot® devices are as safe and intuitive as standard surgical dressings, but are significantly faster and more effective because they contain kaolin, which accelerates the body’s coagulation cascade.1,4

Learn more about QuikClot®


Kaolin impregnated gauze is proprietary to QuikClot® devices

Kaolin is an inert mineral that is nonallergenic1,4 and does not contain human or animal proteins. QuikClot® hemostatic gauzes do not contain shellfish-based ingredients. With the newest generation of QuikClot® products, there is no need to worry about instigating allergic1,4 or exothermic reactions.8 You and your team can treat injuries quickly, controlling bleeding until patients are transported to the hospital or trauma unit.12

Learn more about QuikClot®


QuikClot® devices can help your team be prepared for almost every emergency

QuikClot® devices are kaolin-impregnated, nonwoven gauzes that provide efficient hemostasis solutions on the scene, as well as in the ambulance. They conform to the wound site and the gauze does not break down under pressure. The products come in familiar formats and various sizes and are adaptable to most bleeding emergencies, such as:

  • Motor vehicle accidents
  • Home and workplace accidents
  • Assault wounds
  • Natural disasters
  • Mass casualty events
  • Other bleeding situations

Training & Education: Get to know your QuikClot® EMS products

All QuikClot® products are intuitive and easy to use, as is the training.

Get trained now


How can we serve you better?

Let us help assess the bleeding control needs of your team, department, or entire facility. We can recommend the QuikClot® devices that are right for any bleeding situation you may encounter.

Contact us

References: 1. Trabattoni D, Montorsi P, Fabbiocchi F, Lualdi A, Gatto P, Bartorelli A. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21:1687-1691. 2. Politi L, Aprile A, Paganelli C, et al. Randomized clinical trial on short-time compression with kaolin-filled pad: a new strategy to avoid early bleeding and subacute radial artery occlusion after percutaneous coronary intervention. J Interven Cardiol. 2011;24:65-72. 3. Trabattoni D, Gatto P, Bartorelli A. A new kaolin-based hemostatic bandage use after coronary diagnostic and interventional procedures. Int J Cardiol. 2012;156(1):53-54. 4. Lamb KM, Pitcher HT, Cavarocchi NC, Hirose H. Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy. Open Cardiovasc Thorac Surg J. 2012;5:8-10. 5. Pahari M, Moliver R, Lo D, Pinkerton D, Basadonna G. QuikClot® Interventional™ Hemostatic Bandage (QCI): a novel hemostatic agent for vascular access. Cath Lab Digest. 2010;18(1):28-30. http://www.cathlabdigest.com/articles/QuikClot®-Interventional™-Hemostatic-Bandage-QCI-A-Novel-Hemostatic-Agent-Vascular-Access. Accessed on August 10, 2014. 6. Tactical Combat Casualty Care Guidelines 2 June 2014. http://www.usaisr.amedd.army.mil/pdfs/TCCC_Guidelines_140602.pdf. Accessed March 25, 2015. 7. Margolis J. Initiation of blood coagulation by glass and related surfaces. Journal Physiol 1957;137:95-109. 8. Data on file. 9. Curry N, Hopewell S, Doree C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92. 10. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safetry evaluation of new hemostatic agents, smectite granules, and kaolin covered gauze in vascular injury wound model in swine. J Trauma. 2010;68:269-278. 11. Kheirabadi BS, Scherer MR, Estep JS, Dubick MA, Holcomb JB. Determination of efficacy of new hemostatic dressing in a model of extremity arterial hemorrhage in swine. J Trauma. 2009;67:450-460. 12. Kheirabadi BS. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J. 2011;25-37. 13. Dee KC, Puleo DA, Bizios R. Tissue-Biomaterial Interactions. Hoboken: Wiley & Sons, 2002. 14. Stop the Bleeding Coalition website http://www.stopthebleedingcoalition.com/get-the-facts.html. Updated: 18 July 2014. Accessed 24 February 2016. 15. Blair, J. Pete, and Schweit, Katherine W. (2014). A Study of Active Shooter Incidents, 2000 - 2013. Texas State University and Federal Bureau of Investigation, US Department of Justice, Washington D.C. 2014. 16. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006; 60:S3-S11.

Show ReferencesHide References


 

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Continue